A carregar...
Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study
BACKGROUND: The current standard for induction phase treatment of lupus nephritis is steroid combined with mycophenolate mofetil or pulse intravenous cyclophosphamide (IVC). The lowest dose of IVC recommended for induction therapy is that used in the Euro-Lupus Trial. It is not known whether same cu...
Na minha lista:
| Publicado no: | BMC Nephrol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5055665/ https://ncbi.nlm.nih.gov/pubmed/27717323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-016-0361-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|